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SUMMARY
Theproper functionofneural circuits requiresspatially
and temporally balanced development of excitatory
and inhibitory synapses. However, the molecular
mechanisms coordinating excitatory and inhibitory
synaptogenesis remain unknown. Here we demon-
strate that SRGAP2A and its human-specific paralog
SRGAP2C co-regulate the development of excitatory
and inhibitory synapses in cortical pyramidal neurons
in vivo. SRGAP2A promotes synaptic maturation, and
ultimately the synaptic accumulation of AMPA and
GABAA receptors,by interactingwithkeycomponents
of both excitatory and inhibitory postsynaptic scaf-
folds, Homer and Gephyrin. Furthermore, SRGAP2A
limits the density of both types of synapses via its
Rac1-GAP activity. SRGAP2C inhibits all identified
functions of SRGAP2A, protracting the maturation
and increasing the density of excitatory and inhibitory
synapses. Our results uncover a molecular mecha-
nism coordinating critical features of synaptic devel-
opment and suggest that human-specific duplication
of SRGAP2might have contributed to the emergence
of unique traits of humanneuronswhile preserving the
excitation/inhibition balance.
INTRODUCTION
The assembly and function of neural circuits requires synaptic
excitation and inhibition to be tightly balanced (Nelson and Va-
lakh, 2015). The balanced ratio of excitatory and inhibitory syn-
apses (E/I ratio) and their relative distribution are attained early
during development, before the density of synapses reaches
its mature level (Benson and Cohen, 1996; Soto et al., 2011;
Zhao et al., 2005). Remarkably, the E/I ratio is conserved be-
tween rodents and humans, even though the density of synapses
is significantly higher in human cortical neurons (Defelipe, 2011).
At least in the visual system, the E/I ratio in individual cells is
reached before the onset of sensory experience (Soto et al.,
2011), suggesting that developmental mechanisms set the equi-
librium between the number of excitatory and inhibitory synap-
ses and coordinate their formation. Very little is known about
thesemechanisms. At themolecular level, the assembly of excit-
atory and inhibitory synapses involves almost exclusive sets of
proteins, and the scarcity of genes known to co-regulate the
density or the maturation of both types of synapses has
obscured the identification of general principles for this critical
aspect of cortical circuit development.
We have previously shown that Slit-Robo Rho-GTPase Acti-
vating Protein 2 (SRGAP2) regulates different aspects of cortical
development from the migration and differentiation of pyramidal
neurons (Guerrier et al., 2009) to the maturation and density of
dendritic spines, small protrusions distributed along dendrites
that receive the majority of excitatory synaptic inputs (Charrier
et al., 2012). SRGAP2 encodes a protein highly conserved in
mammals and is one of the few genes specifically duplicated
in the human lineage (Dennis et al., 2012; Sudmant et al.,
2010). The ancestral gene SRGAP2A has undergone two major
partial duplications, which generated a human-specific gene,
SRGAP2C, approximately 2 to 3 million years ago, at a critical
time during evolution coinciding with the emergence of the
Homo lineage (Dennis et al., 2012). SRGAP2C copy number is
remarkably fixed in the human population, and SRGAP2C is
largely co-expressed with SRGAP2A in the developing and adult
human brain (Charrier et al., 2012; Dennis et al., 2012). At the pro-
tein level, SRGAP2A contains three functional domains: a N-ter-
minal F-BAR (Bin, Amphiphysin, Rvs) domain, a central Rho-
GAP (Rho GTPase-Activating Protein) domain specific for the
small GTPase Rac1, and a C-terminal SH3 (Src Homology 3)
domain (Guerrier et al., 2009). SRGAP2A is primarily expressed
in the neocortex during synaptogenesis and accumulates at
excitatory synapses (Charrier et al., 2012; Guerrier et al., 2009),
where it promotes the maturation of dendritic spines and limits
their density in vivo (Charrier et al., 2012). SRGAP2C is a trun-
cated form of SRGAP2A corresponding to the F-BAR domain
lacking its last 49 amino acids (Charrier et al., 2012; Dennis
et al., 2012). We have previously demonstrated that SRGAP2C
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physically interacts with SRGAP2A through its F-BAR domain
and inhibits SRGAP2A function (Charrier et al., 2012). Inactiva-
tion of SRGAP2A, as well as heterologous expression of hu-
man-specific SRGAP2C in mouse cortical pyramidal neurons
in vivo, induces the emergence of human traits of pyramidal
neurons, such as neoteny during spine maturation and higher
morphological complexity due to increased spine density and
longer spine neck (Benavides-Piccione et al., 2002; Charrier
et al., 2012; Elston et al., 2001; Huttenlocher and Dabholkar,
1997; Petanjek et al., 2011).
While the increase in the size and density of dendritic spines,
as well as the delay of their maturation, might have been permis-
sive for the emergence of human cognitive abilities during
evolution (Defelipe, 2011; Geschwind and Rakic, 2013), these
modifications raise fundamental questions about the impact of
human-specific SRGAP2 duplication on the E/I equilibrium.
Increasing excitation in cortical pyramidal neurons can induce
hyperexcitability and has been implicated in cognitive, social,
and behavioral defects observed in neurodevelopmental disor-
ders ranging from epilepsy to intellectual disability and autism
spectrum disorders (Clement et al., 2012; Ramocki and Zoghbi,
2008; Yizhar et al., 2011). The evolutionary recent genomic
fixation of SRGAP2C in modern human population implies the
existence of developmental mechanisms that supported the
coordinated evolution of excitatory and inhibitory synapses
and preserved the E/I ratio.
In the present study, we tested the hypothesis that SRGAP2
paralogs co-regulate the development of excitatory and inhibi-
tory synapses. We demonstrate that SRGAP2A co-regulates
thematuration and the density of excitatory and inhibitory synap-
ses inmouse cortical pyramidal neurons in vivo. Using an in utero
gene replacement strategy in sparse cortical pyramidal neurons,
we uncover the cellular and molecular mechanisms underlying
SRGAP2A function in excitatory and inhibitory synapse develop-
ment.We show that SRGAP2A has the unique property to couple
small GTPase signaling to postsynaptic scaffolding proteins
at both excitatory and inhibitory synapses through physical
interactions with Homer and Gephyrin, respectively. Our results
indicate that expressing SRGAP2C in mouse neurons inhibits all
identified functions of SRGAP2A at synapses, from spine
morphogenesis and inhibitory synapse formation to the accumu-
lation of postsynaptic AMPA and GABAA receptors. Finally, we
show that SRGAP2A inactivation co-regulates excitatory and
inhibitory synaptic transmission. Our results identify a molecular
mechanism coordinating excitatory and inhibitory synapse
development in vivo and suggest that the human-specific dupli-
cation of SRGAP2 has modified the cell biology of cortical pyra-
midal neurons while preserving their E/I integrity.
RESULTS
Inhibition of SRGAP2A by SRGAP2C Protracts the
Maturation and Increases the Density of Inhibitory
Synapses
In the forebrain, most inhibitory synapses contain type A g-Ami-
nobutyric Acid Receptors (GABAARs) that are stabilized by a lat-
tice of Gephyrin molecules underneath the plasma membrane
(Tretter et al., 2012). Gephyrin is the core component of inhibitory
postsynaptic scaffolds and can be used as a marker to label
inhibitory synapses (Tretter et al., 2012). To address the potential
role of SRGAP2 paralogs in inhibitory synaptogenesis, we chose
an approach allowing the comparison of inhibitory and excitatory
synapses at different developmental stages (i.e., juvenile and
adult) with a single cell resolution in vivo. The expression of
SRGAP2 paralogs was manipulated throughout development
using sparse, cortex-specific in utero electroporation (IUE). Neu-
ral progenitors generating layer 2/3 cortical pyramidal neurons
were electroporated at embryonic day 15.5 (E15.5) with short
hairpin RNAs (shRNA) against Srgap2a (Charrier et al., 2012) or
a cDNA encoding SRGAP2C. The co-electroporation of a GFP-
tagged Gephyrin and a cytosolic fluorescent protein (TdTomato)
allowed the visualization of inhibitory synapses and dendritic
spine morphology in neurons optically isolated by confocal mi-
croscopy (Figure 1A). This approach was recently shown to reli-
ably label inhibitory synaptic contacts without affecting synaptic
development or inhibitory neurotransmission (Chen et al., 2012;
van Versendaal et al., 2012).
We examined the density and the size of inhibitory synapses
in oblique apical dendrites of the somatosensory cortex in juve-
nile (Postnatal day 21, P21) and adult mice (>P65). As previously
described (Chen et al., 2012; Knott et al., 2002; Kubota et al.,
2007; van Versendaal et al., 2012), Gephyrin clusters were
distributed along the dendritic shaft (large arrowheads in Fig-
ure 1A), and some were located in dendritic spines (small arrow-
heads in Figure 1A). In juvenile mice (Figures 1B–1E), Gephyrin
cluster density was 0.24 ± 0.01 cluster/mm in control pyramidal
neurons (Figure 1C), which is consistent with previous
reports (Chen et al., 2012). Srgap2a knockdown using shRNA
(shSrgap2) and SRGAP2C expression had similar effects: at
P21, in both conditions, Gephyrin cluster density increased
by !75% (Figures 1C and S1), while Gephyrin cluster size
decreased by !20% (Figures 1D and S2). Unexpectedly, these
effects were associated with a !50% increase in the proportion
of Gephyrin clusters located in dendritic spines (Figure 1E). In
adult control neurons, the density (Figure 1F), size (Figure 1G),
and subcellular distribution (Figure 1H) of Gephyrin clusters
were similar to juvenile control neurons (Figures 1C–1E), indi-
cating that the morphological development of inhibitory synap-
ses was largely complete by P21. By contrast, in SRGAP2A-
deficient or SRGAP2C-expressing neurons, Gephyrin clusters
underwent a substantial growth between juvenile and adult
stages and reached a size undistinguishable from control (Fig-
ures 1D and 1G), suggesting that inhibitory synapses mature
at a slower rate when SRGAP2A is inactivated. Furthermore,
SRGAP2A-deficient and SRGAP2C-expressing neurons main-
tained a higher density of Gephyrin clusters (Figure 1F) and an
enrichment of Gephyrin clusters in dendritic spines (Figure 1H)
into adulthood. We found that 26% ± 1% of Gephyrin clusters
were located in spines in control pyramidal neurons, which is
in agreement with previous studies (Chen et al., 2012; Knott
et al., 2002; Kubota et al., 2007). This percentage rose to
39% ± 2% following Srgap2a knockdown and 39% ± 1%
following SRGAP2C expression, suggesting that local inhibition
at the level of the spine is favored at higher synaptic density
(see also Charrier et al., 2012). Together, these results demon-
strate that (1) SRGAP2A accelerates the growth of inhibitory
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Figure 1. SRGAP2A and Its Human-Specific Paralog SRGAP2C Regulate the Maturation and the Density of Inhibitory Synapses In Vivo
(A) Visualization of inhibitory synapses in sparse layer 2/3 cortical pyramidal neurons after in utero electroporation (IUE) with soluble TdTomato (red) and EGFP-
Gephyrin (EGFP-GPHN, green). Inhibitory synapses in oblique apical dendrites (insets) are located in the dendritic shaft (large arrowheads) or directly in dendritic
spines (small arrowheads). P69: postnatal day 69; shSrgap2: shRNA targeting mouse Srgap2a. Scale bars: 100 mm (top left) and 10 mm (top right and bottom
panels).
(B) Segments of dendrites from layer 2/3 pyramidal neurons expressing a control shRNA (shControl), shSrgap2, or SRGAP2C along with EGFP-Gephyrin
in juvenile mice (P21). The dashed lines indicate the contour of dendrites (from TdTomato). Arrowheads point to examples of Gephyrin clusters in spines. Scale
bar: 1 mm.
(C–H) Quantifications of Gephyrin cluster density ([C], [F]), equivalent (Eq.) diameter ([D], [G]), and proportion of Gephyrin clusters located in spines ([E], [H]) in
juveniles ([C]–[E]) and adult mice ([F]–[H]). Juveniles: nshControl = 32, nshSrgap2 = 36, nSRGAP2C = 31. Adults: nshControl = 21, nshSrgap2 = 23, nSRGAP2C = 22.Mean ± SEM
in (C), (E), (F), and (H). Box plot showing the distribution of the mean value per cell in (D) and (G). ***p < 0.001; **p < 0.01. NS (not significant): p > 0.05, Kruskal-
Wallis test followed by Dunn’s Multiple comparison test.
(I) Similar effects of SRGAP2C expression on the density of dendritic spines (red) and Gephyrin clusters (green) in adult cortical neurons (P > 65). Norm. density:
normalized density. Spines (data from Charrier et al., 2012): nControl = 14 and nSRGAP2C = 12. Gephyrin: same as in (H). ***p < 0.001. NS: p > 0.05, Mann Whitney
test. See also Figures S1 and S2.
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synapses and limits their density in a cell-autonomous manner
and (2) that SRGAP2C antagonizes the function of ancestral
SRGAP2A during inhibitory synapse development. Strikingly,
the protracted maturation and increased density of inhibitory
synapses resulting from SRGAP2A loss of function or heterolo-
gous SRGAP2C expression paralleled the consequences on
dendritic spines (Figures 1I and S1) (Charrier et al., 2012).
Indeed, we have previously shown that in SRGAP2A-deficient
neurons and in SRGAP2C-expressing neurons, spinematuration
is delayed compared to control neurons and spine density is
markedly increased in both juvenile and adult mice (Charrier
et al., 2012). We conclude that SRGAP2 paralogs co-regulate
the development of excitatory and inhibitory synapses in vivo
and that SRGAP2C inhibits all identified functions of SRGAP2A.
SRGAP2A Interacts with Major Components of
Excitatory and Inhibitory Postsynaptic Scaffolds
Themolecular mechanisms underlying the function of SRGAP2A
at excitatory and inhibitory synapses are currently unknown.
Although both types of synapses are assembled from dynamic
networks of protein-protein interactions (Choquet and Triller,
2013), the sets of proteins that compose excitatory and inhibitory
postsynaptic machineries are largely exclusive. SRGAP2A has
a well-characterized Rac1-GAP activity (Guerrier et al., 2009),
but few interacting partners have been identified, especially in
neurons and at synapses. In order to identify other signaling
pathways and protein-protein interaction networks that might
be controlled by SRGAP2, we searched for putative interaction
motifs using sequence analysis (http://elm.eu.org). We identified
a conserved proline-rich motif corresponding to a class II EVH1
binding site (PPMKF, residues P339-F343) in a predicted loop
bridging two a-helixes in the F-BAR domain of SRGAP2 (see
Guerrier et al., 2009 for the predicted secondary structure of
SRGAP2 F-BAR domain). This motif is a canonical binding site
for Homer family proteins (Tu et al., 1998), which are abundant
components of excitatory postsynaptic densities (PSDs) (Sheng
and Hoogenraad, 2007). Homer plays a key role in the assembly
of excitatory postsynaptic scaffolds via its interaction with Shank
(Hayashi et al., 2009), and in the regulation of spine signaling via
its binding to mGluR5, IP3 receptors, and Ryanodine receptors
(Bockaert et al., 2010; Ting et al., 2012). More specifically, Homer
recruits into spines the Shank-GKAP-PSD95 complex, which
ultimately stabilizes AMPA and NMDA glutamate receptors at
the PSD (Hayashi et al., 2009; Sheng and Hoogenraad, 2007;
Tu et al., 1999).
To assess a biochemical interaction between SRGAP2A and
Homer, we isolated protein complexes associated with synaptic
membranes from P15 mouse brains using subcellular fraction-
ation and performed co-immunoprecipitation. Following Homer1
immunoprecipitation, SRGAP2A was detected in western blots
using two specific antibodies directed against its N-terminal
domain or its C-terminal domain (Figure 2A). We noticed that
the form of SRGAP2A immunoprecipitated in complex with
Homer1 in brain lysates ran at a slightly higher apparent molec-
ular weight than the majority of SRGAP2A present in the input.
Although we do not know the basis for this, it might be due to
differences in protein amounts between the input and immuno-
precipitation lanes or to post-translational modifications of
SRGAP2A such as phosphorylation, which is extensive based
on publicly available mass spectrometry data (http://www.
phosphosite.org). We then co-expressed GFP-Homer1c with
hemagglutinin (HA)-tagged SRGAP2A in HEK cells (Figure 2B).
GFP and SRGAP2A-GFP were used as negative and positive
controls, respectively. Using HA immunoprecipitation, we
confirmed that SRGAP2A binds to Homer1c. Importantly, two
point mutations within the class II EVH1 binding motif (P340L/
F343C, EVH1dead mutant) were sufficient to abolish the interac-
tion between SRGAP2A and Homer1c (Figure 2C), validating its
specificity and providing a molecular tool to dissect its role in
synaptic development in vivo (see below).
While SRGAP2A interacts with Homer via a EVH1-binding site
embedded in its F-BAR domain, Gephyrin was recently identified
as a partner of SRGAP2A using an SH3-based photo-trapping
assay (Okada et al., 2011). As mentioned above, Gephyrin forms
high-order oligomers, which provide binding sites for most of
the identified components of inhibitory synapses, including
GABAARs (Fritschy et al., 2008; Tretter et al., 2012). To substan-
tiate this interaction, we modified a Fibronectin intrabody gener-
ated with mRNA display directed against aa 1–113 of Gephyrin
(GPHN.FingR, Gross et al., 2013) and showed that purified
GPHN.FingR efficiently immunoprecipitates Gephyrin (Fig-
ure S3). Using this GPHN.FingR, we confirmed that SRGAP2A
and Gephyrin interact in synaptic fractions from P15 mouse
brains (Figure 2D). We then introduced a point mutation in the
SH3 domain of SRGAP2A (W765A, SH3dead mutant) and
performed co-immunoprecipitation experiments in HEK cells.
EGFP-Gephyrin co-immunoprecipitated with HA-SRGAP2A
but not with the SH3dead mutant (Figure 2E). We then wondered
whether SRGAP2A colocalizes with Gephyrin in cortical neurons.
We have previously shown that SRGAP2A accumulates post-
synaptically and colocalizes with Homer1 clusters at excitatory
synapses (Charrier et al., 2012). Using immunocytochemistry
in dissociated cortical neurons after 17 days in vitro, we found
that SRGAP2A associates with the majority of both Homer1
and Gephyrin clusters (Figures 2F and 2G). Remarkably, the
EVH1dead and SH3dead mutants of SRGAP2A showed a
decreased association with dendritic spines and Gephyrin clus-
ters, respectively (Figure S4). Together, these results demon-
strate that SRGAP2A has the unique property to interact, via
two distinct domains, with two major components of excitatory
and inhibitory postsynaptic scaffolds (Figure 2H).
Molecular Determinants of SRGAP2-Dependent Spine
Development
To determine the mechanisms underlying this co-regulation, we
first investigated the molecular determinants of SRGAP2A func-
tion in the development of dendritic spines. To this end, we
developed an in utero gene replacement strategy, which allows
the characterization of cell-autonomous mechanisms of synap-
tic development in vivo (Figures 3A–3E). This approach consists
in knocking down endogenous Srgap2a in isolated layer 2/3
cortical pyramidal neurons and to replace it with mutant forms
of SRGAP2A. We used an shRNA vector that also drives the
expression of mVenus to visualize neuronal morphology. The
co-electroporation at E15.5 of shSrgap2, which targets mouse
Srgap2a but not human SRGAP2A (hSRGAP2A, Charrier et al.,
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2012), with hSRGAP2A cDNA (1 mg/ml each), fully rescued spine
density and morphology at P21 (Figures 3A–3E), validating this
strategy for the molecular dissection of SRGAP2A function in
synaptic development in vivo.
To test the function of SRGAP2A-Homer interaction, we re-
placed endogenous SRGAP2A with the EVH1dead mutant (Fig-
ure 3B) in sparse cortical pyramidal neurons. We then analyzed
spine morphology and density in juvenile mice. At that stage,
the size of the spine head can be used as an indicator of spine
maturation (Charrier et al., 2012; Harris and Stevens, 1989), while
spine density and spine neck length contribute to dendritic and
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Figure 2. SRGAP2A Interacts with Homer1 and Gephyrin
(A) Co-immunoprecipitation (coIP) of endogenous SRGAP2A and Homer1 in synaptic fractions from P15 mouse brains. SRGAP2A was co-immunoprecipitated
using anti-Homer1 antibody and detected in western blot using two specific antibodies directed against its N-terminal domain (left) and its C-terminal domain
(right). IB: immunoblot; a: anti.
(B) CoIP of SRGAP2A-HA and GFP-HOMER1c in HEK cells.
(C) Mutation of the class 2 EVH1 binding motif of SRGAP2A (P340L/F343C, EVH1dead mutant) disrupts its interaction with HOMER1c in HEK cells.
(D) CoIP of endogenous SRGAP2A and Gephyrin (GPHN) in synaptic fractions isolated from P15 mouse brains using GPHN.FingR.
(E) SRGAP2A interacts with EGFP-GPHN via its SH3 domain in HEK cells. SRGAP2A SH3dead mutant contains a W765A point mutation.
(F) Single section confocal images of endogenous SRGAP2A with Homer1 or GPHN in dissociated mouse cortical neurons after 17 days in vitro reveal close
association (arrowheads) between SRGAP2A and both excitatory and inhibitory synapses. Scale bar: 2 mm.
(G) Histogram showing the fraction of Homer1 and Gephyrin clusters associated with SRGAP2A immunoreactivity (association index). The control (Ctr) values
correspond to the random fraction of Homer1 and Gephyrin clusters associated with SRGAP2A in mismatched images. HOMER1 and HOMER1 Ctr: n = 21,
GPHN and GPHN Ctr: n = 23. Mean ± SEM. ***p < 0.001, Mann-Whitney test.
(H) Schematic of SRGAP2A interactions with Homer and Gephyrin.
See also Figures S3 and S4.
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(Higley and Sabatini, 2008; Yuste, 2013). The EVH1dead mutant
did not rescue spine head size, which was similar to shSrgap2
condition (Figures 3A, 3D, and S2), indicating a deficit in
spine maturation. The EVH1dead mutant, however, completely
rescued spine neck length and partially rescued spine density
(Figures 3A, 3C, and 3E). These effects mimicked shRNA-medi-
atedHomer1 knockdown in pyramidal neurons in vivo (Figure S5;
see also Hayashi et al., 2009), supporting the notion that
SRGAP2A helps the formation of the Homer-based postsynaptic
scaffold during spine maturation (see also Figures 6A–6F).
To assess the contribution of the Rac1-GAP activity of
SRGAP2A, we inserted two point mutations within hSRGAP2A
(R527L/K566A; GAPdead mutant) to generate a protein, which
is no longer able to promote the GTPase activity of Rac1 and
cannot bind to GTP-Rac1 (Guerrier et al., 2009) (Figure 3B).
When expressed in replacement of endogenous SRGAP2A, the
GAPdead mutant did not rescue spine density and spine neck
length (Figures 3A, 3C, and 3E). However, spine head size was
similar to control condition (Figures 3A and 3D). These results
are consistent with the function of Rac1 in dendritic spines
(e.g., Cerri et al., 2011; Luo et al., 1996) and demonstrate that
the Rac1-GAP activity of SRGAP2A limits spine neck length
and spine density but is not required for themorphological matu-
ration of dendritic spines.
We then tested the role of the SH3 domain of SRGAP2A. In
addition to Gephyrin, the SH3 domain was previously shown to
interact with Actin-regulating proteins (Okada et al., 2011), sug-
gesting that it might regulate spine morphology. Unexpectedly,
the SH3dead mutant behaved as wild-type hSRGAP2A
(Figures 3A–3E), suggesting that the SH3 domain of SRGAP2A
is dispensable for dendritic spine development. Together, these
results demonstrate that SRGAP2A couples Rac1-dependent
signaling to excitatory PSDs via Homer1 and coordinates the
regulation of spine density with the rate of their maturation
in vivo.
Molecular Determinants of SRGAP2-Dependent
Inhibitory Synapse Development
To dissect the molecular mechanisms underlying SRGAP2A
function in inhibitory synapse development, we used the
in vivo approach used above for dendritic spines and selectively
replaced endogenous SRGAP2A with mutated forms of
hSRGAP2A in sparse layer 2/3 cortical pyramidal neurons using
IUE (Figures 4A and 4B). The increased density and reduced size
of Gephyrin clusters induced by mouse Srgap2a knockdown
were fully rescued by the expression of hSRGAP2A in P21
cortical pyramidal neurons (Figures 4B–4E). We then replaced













































































































































































































Figure 3. Molecular Dissection of SRGAP2A Function in Spine Development In Vivo
(A) Representative segments of oblique dendrites expressing mVenus from P21 mice in control condition (shControl), after knockdown of mouse Srgap2a
(shSrgap2), replacement with hSRGAP2A or replacement with the indicated mutants in layer 2/3 cortical neurons using IUE. Scale bar: 2 mm.
(B) Schematic of hSRGAP2A mutants used in (A).
(C) Mean spine density (± SEM).
(D) Quantification of spine head widths.
(E) Quantification of spine neck lengths.
nshControl = 19, nshSrgap2 = 20, nshSrgap2+hSRGAP2A = 18, nshSrgap2+EVH1dead = 24, nshSrgap2+GAPdead = 25, nshSrgap2+SH3dead = 23. ***p < 0.001; *p < 0.05. NS:
p > 0.05, Kruskal-Wallis test followed by Dunn’s Multiple comparison test. Green, orange, gray, and blue symbols: comparison with shControl, shSrgap2,
shSrgap2+hSRGAP2A, shSrgap2+GAPdead, respectively. See also Figures S2, S5, and S6.
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significant effects on spinematuration and spine density (Figures
3A–3D), expression of the EVH1dead mutant did not affect the
density, size, or distribution of Gephyrin clusters (Figures 4B–
4E; see also Figure S6). These results indicate that SRGAP2A
binding to Homer does not affect the development of inhibitory
synapses. They also suggest that SRGAP2-dependent regula-
tions of excitatory synaptic development do not elicit indirect
or homeostatic adaptations of inhibitory synaptic development.
We then analyzed the role of the Rac1-GAP activity and of the
SH3 domain of SRGAP2A. Replacement of SRGAP2A by the
GAPdead mutant increased the density of Gephyrin clusters to
the same extent as shSrgap2-mediated knockdown. However,
the GAPdead mutant rescued the size of Gephyrin clusters,
which was similar to control (Figures 4B–4D). This uncovers
the requirement of the Rac1-GAP activity of SRGAP2A for
setting the density of inhibitory synapses but not for their matu-
ration. Replacement of SRGAP2A with the SH3dead mutant had
complementary effects: it rescued the effect of shSrgap2 on Ge-
phyrin cluster density but not on Gephyrin cluster size (Figures
4B–4D), indicating that SRGAP2A promotes inhibitory synaptic
growth through its direct interaction with Gephyrin. Interestingly,
the ratio of Gephyrin clusters located on dendritic spines
increased with higher density, independently of Gephyrin cluster
size (Figures 4C–4E).
To further substantiate the importance of Gephyrin interaction
with the SH3 domain of SRGAP2A in inhibitory synapse develop-
ment, we performed the reverse experiment and analyzed the
consequences of altering the SRGAP2A binding site on Ge-
phyrin. The SRGAP2A binding site on Gephyrin was previously
identified as a PGLP motif in the C-terminal E domain of Ge-
phyrin (Okada et al., 2011). Disruption of the PGLPmotif by intro-
duction of two point mutations (P603A/P606A, GPHN_PAPA
mutant) abolished Gephyrin interaction with SRGAP2A (Fig-
ure 5A). We then designed an shRNA directed against Gephyrin
(shGPHN, Figure 5B) and an shGPHN-resistant Gephyrin
construct (GPHN*). Using IUE, we replaced endogenous Ge-
phyrin with either GPHN* or GPHN*_PAPA mutant in sparse
cortical pyramidal neurons (Figure 5C). In juvenile mice, GPHN*
and GPHN*_PAPA clusters were present at the same density
(Figure 5D). However, GPHN*_PAPA formed smaller clusters
than GPHN* (Figure 5E). These results phenocopied what







































































































































































































IUE E15.5  →  P21
Figure 4. Molecular Dissection of SRGAP2A Function in Inhibitory Synaptic Development In Vivo
(A) Schematic: segments of oblique dendrites of layer 2/3 cortical pyramidal neurons were imaged from P21 mice following sparse IUE. EGFP-Gephyrin (yellow)
labels inhibitory synapses, TdTomato (red) allows the visualization of dendritic morphology.
(B) EGFP-Gephyrin clusters in representative segments of dendrites in control condition (shControl) or after in utero replacement ofmouseSrgap2awith indicated
mutants of hSRGAP2A. For clarity, dashed lines define the contours of TdTomato fluorescence in dendrites. Scale bar: 1 mm.
(C–E) Quantification of Gephyrin cluster density (C), Gephyrin cluster equivalent (Eq.) diameter (D), and mean proportion of Gephyrin clusters located in dendritic
spines (±SEM) (E). nshControl = 32, nshSrgap2 = 36, nshSrgap2+hSRGAP2A = 31, nshSrgap2+EVH1dead = 30, nshSrgap2+GAPdead = 32, nshSrgap2+SH3dead = 31. ***p < 0.001; *p <
0.05. NS: p > 0.05, Kruskal-Wallis test followed by Dunn’s Multiple comparison test. Green, Orange, gray: comparison with shControl, shSrgap2 and
shSrgap2+hSRGAP2A, respectively. See also Figure S6.
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(Figure 5F) and demonstrate that SRGAP2A specifically requires
interaction with Gephyrin to regulate inhibitory synapse matura-
tion. Altogether, these results show that the density and subcel-
lular distribution of inhibitory synapses depend on the Rac1-GAP
activity of SRGAP2A while direct binding of SRGAP2A to Ge-
phyrin promotes their maturation.
Regulation of Excitatory and Inhibitory Postsynaptic
Scaffold Assembly by SRGAP2
We next tested if and how SRGAP2A inactivation impacts the
formation of molecular scaffolds and the recruitment of iono-
tropic Glutamate and GABAA receptors during synaptic matura-
tion. To address this question, we used several independent
approaches. First, we isolated excitatory synaptic membranes
using subcellular fractionation from juvenile (P15) wild-type and
Srgap2a knockout (KO) brains and compared the abundance
of major synaptic proteins using quantitative western blot
analysis (Figure 6A). We observed a homogenous decrease
(!25%) in the amount of the postsynaptic scaffolding proteins
Homer1 and PSD-95, as well as in the level of AMPA (GluA1,
GluA2) andNMDA (GluN2B, GluN2A) receptor subunits in synap-
tic fractions from the SRGAP2A-deficient brains (Figures 6A
and 6B; comparison of the effect between proteins: p > 0.05,
ANOVA). Because inhibitory synapses cannot be isolated using
subcellular fractionation, we compared the consequences of
SRGAP2A inactivation on glutamatergic and GABAergic synap-
ses using immunocytochemistry and live cell imaging in cultured
cortical neurons. In agreement with our biochemical and in vivo
morphological data, Srgap2a knockdown in dissociated cortical
neurons following lentiviral infection decreased the fluorescence
associated with endogenous Homer1, PSD95, and Gephyrin
clusters to a similar extent (Homer1: 60% ± 2%, PSD95:
66% ± 2%, Gephyrin: 66% ± 2% of the control value; Figures
6C and 6D). To estimate the postsynaptic accumulation of excit-
atory and inhibitory neurotransmitter receptors, we expressed
low levels of super-ecliptic (SEP)-tagged receptor subunits,
namely GluA2 for AMPA receptors (Lu et al., 2009) and g2 for
GABAARs (Tretter et al., 2012). SEP is a pH-sensitive variant of
GFP, which enables the specific visualization of receptors pre-
sent at the plasma membrane in live neurons (Miesenbo¨ck
et al., 1998). SEP-tagged receptor subunits and shRNA vectors
were introduced into cortical pyramidal neurons using IUE at
E15.5, followed by dissociation and culture at E18.5, and live im-
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Figure 5. Specific Interaction between SRGAP2A and Gephyrin Promotes Inhibitory Synapse Maturation
(A)Mutation of the binding site of SRGAP2A onGephyrin (P603A/P606A, namedGPHN_PAPAmutant) disrupted the interaction betweenSRGAP2A andGephyrin
in coIP experiment in HEK cells.
(B) Validation of shGPHN in HEK cells using western blot (left) and quantification. n = 3, mean ± SEM.
(C) Representative segments of dendrites from P21mice after in utero replacement of endogenous Gephyrin with EGFP-tagged GPHN* or GPHN*_PAPA (green),
and co-expression of soluble TdTomato (red). Scale bar, 2 mm.
(D and E) Quantification of gephyrin cluster density (D) and equivalent diameter (E). nshGPHN+GPHN* = 15 (from three mice), n shGPHN+GPHN*_PAPA = 15 (from four
mice). ***p < 0.001; NS: p > 0.05, Mann-Whitney test.
(F) Replacement of endogenous GPHN with GPHN*_PAPA mutant and replacement of endogenous SRGAP2A with hSRGAP2A SH3dead mutant have similar
effects. The equivalent (eq.) diameter was normalized to the average value in shGPHN+GPHN* and shSrgap2+hSRGAP2A, respectively. ***p < 0.001. NS:
p > 0.05, Kruskal-Wallis test, followed by Dunn’s Multiple comparison test.
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significantly decreased the size of both GluA2-containing gluta-
mate receptor clusters and g2-containing GABAAR clusters to
62% ± 3% and 68% ± 5% of the control value, respectively (Fig-
ures 6E and 6F). Remarkably, SRGAP2C expression induced a
similar decrease of receptor cluster size (GluA2: 62% ± 3% of
the control value, g2-GABAAR: 60% ± 2% of the control value)
(Figures 6E and 6F). Together, these results further support the
notion that SRGAP2 paralogs co-regulate excitatory and inhibi-
tory synaptic maturation through the recruitment of structural
components and neurotransmitter receptors during the assem-
bly of postsynaptic molecular machineries.
Finally, we assessed how SRGAP2A inactivation might affect
synaptic transmission. It is difficult to predict how an increase
in synaptic density associated with decreased neurotransmitter
receptor accumulation and increased morphological complexity
(i.e., longer spine neck and more inhibitory synapses in spines)
might impact synaptic currents. To address this issue, we per-
formedwhole-cell patch-clamp recording of miniature excitatory
and inhibitory postsynaptic currents (mEPSCs and mIPSCs,
respectively) in brain slices from juvenile (P20–P25) mouse
brains. We compared layer 2/3 cortical pyramidal neurons in
utero electroporated with shSrgap2 (identified based on their
fluorescence) and neighboring non-electroporated control neu-
rons (Figures 6G–6L). Although we did not detect any difference
in the amplitude of mEPSCs (Average amplitude: 19 ± 1 pA in
both control and shSrgap2 neurons, Figure 6H) and mIPSCs
(average amplitude: 58 ± 1 pA in control, 56 ± 1 pA in shSrgap2,
Figure 6K), we found that SRGAP2A inactivation induced a mild
decrease in the frequency of both mEPSCs (mean interevent
interval: 70 ± 1ms in control, 89 ± 1ms in shSrgap2 neurons, Fig-
ure 6I) and mIPSCs (Mean interevent interval: 87 ± 1 ms in con-
trol, 116 ± 1ms in shSrgap2 neurons, Figure 6L). Similar changes
were observed in Srgap2a KOmice (data not shown). Our results
suggest that SRGAP2A-deficient synapses are more frequently
electrically ‘‘quiet’’ when recorded in the soma of juvenile
neurons. This is consistent with the delayed maturation of post-
synaptic scaffolds and an increased compartmentalization of
synaptic inputs (see Araya et al., 2014). We should be cautious,
however, that synaptic currents originating form dendritic synap-
ses (which represent the vast majority of synapses) are usually
poorly detected in somatic voltage-clamp recordings due to
space-clamp issues in pyramidal neurons (e.g., Williams and
Mitchell, 2008; Spruston and Johnston, 2008). Therefore, it is
possible that our recordings do not fully account for subtle
changes in synaptic transmission that might happen in den-
drites. Nonetheless, these results reinforce our main finding
that SRGAP2A co-regulates the development of excitatory and
inhibitory synapses and indicates that it maintains the equilib-
rium between excitatory and inhibitory synaptic transmission.
DISCUSSION
In the present study, we report that SRGAP2A, which is ex-
pressed in all mammals, co-regulates the development of excit-
atory and inhibitory synapses in cortical pyramidal neurons
in vivo. Our results characterize a mechanism—the first to our
knowledge—coupling the regulation of synapse number and
synapse maturation at both excitatory and inhibitory synapses
(Figure 7). They uncover molecular determinants by which
SRGAP2A links major excitatory and inhibitory scaffolding mole-
cules to its Rac1-GAP activity. Using point mutagenesis and an
in utero gene replacement strategy in sparse cortical neurons,
we demonstrate that SRGAP2A binding toHomer1 andGephyrin
promotes the maturation of excitatory and inhibitory synapses,
respectively, while its Rac1-GAP activity limits the density of
both excitatory and inhibitory synapses. We show that the hu-
man-specific copy SRGAP2C inhibits all functions of SRGAP2A,
which introduces cellular and molecular innovations during syn-
aptic development that are characteristic features of human neu-
rons, such as their protracted maturation and their increased
density of synapses (Benavides-Piccione et al., 2002; Charrier
et al., 2012; Elston et al., 2001; Huttenlocher and Dabholkar,
1997; Petanjek et al., 2011). Finally, we show that the co-regula-
tion of the cell biology of excitatory and inhibitory synaptic
development by SRGAP2A alsomaintains the proper equilibrium
between excitatory and inhibitory synaptic transmission. We
postulate that the unique properties of SRGAP2A in the coordi-
nation of excitatory and inhibitory synaptic development allowed
the preservation of neuronal integrity following its partial human-
specific duplications and may have been fundamental for the
fixation of SRGAP2C in the human population.
MechanismCoordinating the Development of Excitatory
and Inhibitory Synapses
So far, the mechanisms underlying the development of excit-
atory and inhibitory synapses have been studied separately,
and little is known on the development of inhibitory synapses.
This might be due to the great diversity of inhibitory synapses,
the fact that they represent a small percentage (10% to 15%)
of the total number of synapses in the neocortex and the
difficulty to isolate them biochemically and morphologically
compared with excitatory synapses associated with dendritic
spines. Furthermore, although numerous molecules have been
implicated in excitatory synaptic development (McAllister,
2007; Shen and Scheiffele, 2010), we still lack an integrated
view of the mechanisms orchestrating synaptic maturation and
determining synaptic density and distribution in vivo. Our results
uncover shared molecular determinants of excitatory and inhib-
itory synaptic development in cortical pyramidal neurons and
identify SRGAP2A as a major architect regulating the density,
geometry, subcellular distribution, and timing of maturation of
both excitatory and inhibitory synapses. By combining biochem-
ical, cell biological, and structure-function analyses in vivo, we
characterized molecular interactions of SRGAP2A with binding
partners and their functional relevance to synaptic development.
We found that SRGAP2A promotes the maturation of both excit-
atory and inhibitory synapses via a class II EVH1 binding motif
embedded in its F-BAR domain and via its SH3 domain, which
interact with two key structural components of excitatory and
inhibitory postsynaptic scaffolds: Homer and Gephyrin, respec-
tively. It is not clear at this stage how SRGAP2A interactions
with Homer and Gephyrin promote the assembly of excitatory
and inhibitory postsynaptic scaffolds. One possibility is that
SRGAP2A promotes the local recruitment of these scaffolding
proteins to nascent synapses by interacting with highly curved
membrane structures such as filopodia and spines (see Guerrier
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et al., 2009) or by coupling them with other as-yet-unidentified
proteins involved in synaptic adhesion or serving as synaptic or-
ganizers. Another possibility is that SRGAP2A induces confor-
mational changes favoring the oligomerization or the scaffolding
properties of Homer and Gephyrin (Hayashi et al., 2009; Tretter
et al., 2012). Nonetheless, SRGAP2A inactivation decreased
the local accumulation of scaffolding molecules and neurotrans-
mitter receptors at both excitatory and inhibitory synapses,
which were less frequently detected in somatic voltage-clamp
experiments in juvenile layer 2/3 cortical pyramidal neurons.
Importantly, the possibility to dissociate the regulation of excit-
atory and inhibitory synaptic maturation in individual neurons
by specifically disrupting SRGAP2A interaction with Homer or
Gephyrin clearly indicates that SRGAP2A and SRGAP2C control
a cell-autonomous, developmental mechanism rather than a ho-
meostatic or adaptive response.
Our in vivo molecular dissection of SRGAP2 function in excit-
atory and inhibitory synaptic development also demonstrates
that the Rac1-GAP activity of SRGAP2A limits the density of
both excitatory and inhibitory synapses and concomitantly re-
stricts their compartmentalization by controlling the length of
the spine neck and the occurrence of inhibitory synapses in
spines (Alvarez and Sabatini, 2007; Chiu et al., 2013; Yuste,
2011). Remarkably, these effects did not require direct binding
of SRGAP2A to Homer or Gephyrin. In the neocortex, previous
studies have implicated Rac1 signaling in the regulation of syn-
aptic density, functional plasticity, critical periods, and neurode-
velopmental disorders (Cahill et al., 2009; Cerri et al., 2011; Luo
et al., 1996). Our present results highlight SRGAP2 as a key
determinant of the morphological complexity of cortical pyrami-
dal neurons and suggest major functional implications of the in-
hibition of Rac1 GTPase signaling modulation by SRGAP2A in
the evolution of human synapses.
Molecular Regulation of Synaptic Development by
Human-Specific SRGAP2C
Our results indicate that human-specific duplications of
SRGAP2 resulted in a loss-of-function phenotype since
SRGAP2C inhibits all identified functions of SRGAP2A.
SRGAP2C expression mimics the disruption of SRGAP2A
binding to Homer and Gephyrin and the inactivation of its
Rac1-GAP activity, indicating that inhibition of the ancestral pro-
tein by its human-specific copy alleviates both structural and
signaling constraints on synaptic development. Mechanistically,
SRGAP2C heterodimerizes with SRGAP2A (Charrier et al.,
2012), but it is unclear how it inhibits its function in neurons.
Indeed, SRGAP2C might prevent the proper targeting of
SRGAP2A to synapses; it might also interfere with SRGAP2A in-
teractions with its partners by steric hindrance, by direct compe-
tition, or bymodifying SRGAP2A conformation, aswas shown for
other proteins containing both a F-BAR domain and an SH3
domain (Rao et al., 2010).
The unique property of SRGAP2A to bind both Homer and Ge-
phyrin, two important scaffolding molecules during synaptogen-
esis expressed in virtually all excitatory and inhibitory synapses,
suggests that SRGAP2C may universally modify synaptic devel-
opment in human cortical pyramidal neurons, and maybe in
other neuronal subtypes where it is expressed. The oligomeriza-
tion properties of Homer and Gephyrin provide structural plat-
forms for the assembly of excitatory and inhibitory synapses
(Hayashi et al., 2009; Okabe, 2007; Tretter et al., 2012). There-
fore, we postulate that SRGAP2C decelerates the assembly of
postsynaptic scaffolds without altering the general principles of
Figure 6. SRGAP2A Regulates the Assembly of Excitatory and Inhibitory Postsynaptic Scaffolds
(A and B) Representative western blots (A) and quantifications (B) of the synaptic abundance of the indicated proteins in P15 wild-type (WT) and Srgap2a KO
brains (n = 4). Mean ± SEM.
(C) Immunofluorescence of endogenous proteins in cortical neurons cultured for 17 to 18 days in control condition (shControl) or after Srgap2a knockdown
(shSrgap2). Scale bar, 2 mm.
(D) Normalized fluorescence intensity (Norm. Fluo.) associated with clusters of the indicated proteins in shControl and shSrgap2 conditions (n = 40–42 cells).
Mean ± SEM.
(E) Live imaging of SEP-GluA2 and SEP-g2 GABAA receptors in control pyramidal neurons, after Srgap2a knockdown or after SRGAP2C expression (20–22 days
in vitro). Scale bar: 2 mm.
(F) Mean receptor cluster size in the conditions described above. SEP-GluA2: nshControl = 34, nshSrgap2 = 35, nSRGAP2C = 32 ; SEP-g2: nshControl = 36, nshSrgap2 = 25,
nSRGAP2C = 35. Mean ± SEM.
(G) Representative traces of mEPSCs in control (black) and shSrgap2-electroporated (red) neurons.
(H and I) Quantification of mEPSC amplitude (nControl = 2,883 from five cells, nshSrgap2 = 2,811 from five cells) and interevent intervals (nControl = 7,232, nshSrgap2 =
6,587). Cumul. Prob.: cumulative probability. Inset indicates the mean frequency per cell (± SEM).
(J) Representative traces of mIPSCs in control (black) and shSrgap2-electroporated (red) neurons.
(K and L) Quantification of mIPSC amplitude (nControl = 4,370 from seven cells, nshSrgap2 = 4,125 from seven cells) and interevent intervals (nControl = 11,520,
nshSrgap2 = 8,262). Inset indicates the mean frequency per cell (± SEM).
***p < 0.001. NS: p > 0.05, Mann-Whitney test or Kruskal-Wallis test followed by Dunn’s multiple comparison test (F).
Figure 7. Summary of the Mechanism Underlying the Coordina-
tion of Excitatory and Inhibitory Synaptic Development by SRGAP2
Paralogs
See text for details.
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synaptic development. This hypothesis is supported by the ho-
mogenous decrease in the local accumulation of postsynaptic
markers such as Homer1, PSD-95, NMDA receptors, AMPA re-
ceptors, Gephyrin, and GABAA receptors in our biochemical and
cell biological experiments. This is also consistent with mass
spectrometry analyses of human versus rodent PSDs indicating
that the synaptic proteome and interactome are evolutionary
conserved (Baye´s et al., 2012; Shanks et al., 2012). We should
emphasize here that assembly of the Homer- and Gephyrin-
based postsynaptic scaffolds might also be the target of other
evolutionary mechanisms. Recently, the great-ape microRNA
mir-1271, which is robustly expressed in the human forebrain,
was shown to downregulate both Homer1 and Gephyrin expres-
sion (Jensen and Covault, 2011).
Potential Implications for the Human Brain
Based on transcriptome analysis of the developing human brain
(http://www.brainspan.org) and on our previously published re-
sults (Charrier et al., 2012), it is likely that SRGAP2A is partially
inhibited by SRGAP2C in human neurons. We have previously
shown that the consequence of Srgap2a inactivation is dose-
dependent in juvenile mice but that Srgap2a haploinsufficency
ultimately leads in adults to an increase in spine size and density
similar to its constitutive genetic inactivation (Charrier et al.,
2012). Different levels of SRGAP2A inhibition would therefore
mainly affect early cortical circuits and the timing of their matu-
ration so that spatiotemporal modulations of SRGAP2A and
SRGAP2C expression may contribute to the higher level of
neoteny characterizing prefontal neocortical areas (Geschwind
and Rakic, 2013).
Recent studies have emphasized the importance of pro-
tracting synaptic maturation and increasing the morphological
complexity of human cortical pyramidal neurons in synaptic
physiology and cognitive development. Although heterochrony
may contribute to the high vulnerability of human synapses to
perturbations, it is thought to extend the period of developmental
plasticity and reinforce the role of the environment in the assem-
bly of human cortical circuits (Geschwind and Rakic, 2013; Varki
et al., 2008). Hence, accelerated timing of neuronal and synaptic
maturation, as caused by haploinsufficiency in the synaptic gene
SYNGAP1, has been associated with autism spectrum disorders
and intellectual disability (Clement et al., 2012; Courchesne
et al., 2007; Pinto et al., 2010). Furthermore, the higher morpho-
logical complexity of human cortical pyramidal neurons and the
new geometry of dendritic spines may require more local routes
for the trafficking of synaptic proteins, affect the propagation
and the integration of spine signaling, modify the computational
properties of cortical neurons, and enforce the rearrangements
of cortical circuits (Alvarez and Sabatini, 2007; Chiu et al.,
2013; Cui-Wang et al., 2012; Geschwind and Rakic, 2013;
Spruston, 2008; Yuste, 2013). As a consequence, the pheno-
typic outcomes of gene mutations affecting synaptic develop-
ment and function (Krumm et al., 2014; Parikshak et al., 2013;
Ting et al., 2012; Zoghbi and Bear, 2012) might differ between
species. In the future, characterizing the cell biology of human
neurons and the specificities of human synaptic development
should provide new insights into the etiology of neurodevelop-
mental and psychiatric disorders.
EXPERIMENTAL PROCEDURES
Animals
All animals were handled according to protocols approved by French author-
ities and the Institutional Animal Care and Use Committee at Columbia Univer-
sity, New York. Timed-pregnant female mice were maintained in a 12 hr light/
dark cycle and obtained by overnight breeding with males of the same strain.
For timed-pregnant mating, noon after mating is considered E0.5. Juveniles
correspond to mice between postnatal day (P) 21 and P23. Adults correspond
to mice between P65 and P75. The Srgap2 gene trapped allele (B6;129P2-
Srgap2Gt(XH102)Byg/Mmcd) has been described previously (Charrier et al.,
2012). Mice homozygous for this allele were referred to as Srgap2a KO.
In Utero Cortical Electroporation and Slice Preparation
In utero cortical electroporation was performed at E15.5. See Supplemental
Experimental Procedures for detailed methods.
Primary Neuronal Culture, Lentiviral Infection, Live Imaging, and
Immunocytochemistry
Primary cultures were performed as described previously (Charrier et al., 2012)
with few modifications. Please refer to Supplemental Experimental Proce-
dures for details.
Cell Line Culture, Transfection, and Lysis
See Supplemental Experimental Procedures.
Subcellular Fractionation
Subcellular fractionation was performed from P15 mouse brains as described
in Pe´rez-Otan˜o et al. (2006) with minor modifications. See Supplemental
Experimental Procedures for details.
Co-Immunoprecipitation and Western Blotting
Co-immunoprecipitation, western blotting, and antibodies used in this study
are described in Supplemental Experimental Procedures.
Confocal Image Acquisition and Analysis
Confocal images of isolated electroporated neurons in slices were blindly
acquired and analyzed as detailed in Supplemental Experimental Procedures.
Numbers of animals and dendrites analyzed per condition are indicated in
Table S1.
Live Cell Imaging and Analysis
Live cell imaging was performed at 37"C on a spinning disc confocal micro-
scope as detailed in Supplemental Experimental Procedures.
Constructs and shRNAs
Plasmids are described in Supplemental Experimental Procedures.
Electrophysiology
Electrophysiology recordings are described in Supplemental Experimental
Procedures.
Statistics
Histograms represent mean SEM. Whiskers in the box plots represent 5-95
percentile. Details on statistical procedures and data representation can be
found in Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.neuron.2016.06.013.
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